ArticleAnnals of translational medicine2021

Treatment of MGMT promoter unmethylated glioblastoma with PD-1 inhibitor combined with anti-angiogenesis and epidermal growth factor receptor tyrosine kinase inhibitor: a case report.

Zheng Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.